Labetalol Hydrochloride Tablet, Film Coated
Product Images NDC 72888-468

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 72888-468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Labetalol Hydrochloride Tab 300 mg 100s)

This is a description of Labetalol Hydrochloride tablets containing 300 mg per tablet. The storage temperature is recommended to be between 20°C to 25°C. The usual dosage instructions can be found in the accompanying literature. It is advised to keep this medication out of reach of children in a tight, light-resistant container with a child-resistant closure. The package insert is available online at the provided website. The tablets are in a pack of 100 and are for prescription use only. Distributed by Advagen Pharma Ltd., East Windsor, NJ, USA, and manufactured by Rubicon Research Ltd., Thane, India.*

FDA Label Image

"image Description" (Labetalol Hydrochloride Tab 300 mg 500s)

This text provides detailed information about Labetalol Hydrochloride tablets, each containing 300 mg of the active ingredient. It includes storage instructions, dosing guidance, safety precautions for keeping medications away from children, and details on proper dispensing. The text also mentions a link to the package insert for further details. Additionally, it specifies the distributor and manufacturer details along with their locations.*

FDA Label Image

"image Description" (Labetalol Hydrochloride Tab Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.